Angiotensin Converting
Assessment of adverse drug reactions of angiotensin converting enzyme (ace) inhibitors and angiotensin receptor blockers (arbs) among sudanese patients
... with angiotensin converting enzyme (ACE) inhibitors prevents progression from micro albuminuria to overt nephropathy, and in overt nephropathy decreases the gradual loss of renal function beyond its blood ...
5
Evaluation of G2350A Polymorphism of the Angiotensin-Converting Enzyme (ACE) Gene in Chronic Kidney Disease
... 17. Chang, H.R., Cheng, C.H., Shu, K.H., Chen, C.H., Lian, J.D., Wu, M.Y. Study of the polymorphism of angiotensinogen, angiotensin- converting enzyme and angiotensin receptor in type II diabetes ...
5
Comparing the effect of Angiotensin-Converting Enzyme Inhibitors versus Angiotensin Receptor Blockers in heart failure patients with type 2 diabetes mellitus: a systematic review
... of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in heart fail- ure patients with type 2 diabetes mellitus (Table ...
5
Renal and Cardiovascular Effects of Angiotensin-Converting Enzyme Inhibitor Plus Angiotensin II Receptor Antagonist Therapy in Children With Proteinuria
... of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists for children with protein- uria of renal origin reduced proteinuria significantly, compared with baseline or ...
8
Observational study of brain atrophy and cognitive decline comparing a sample of community dwelling people taking angiotensin converting enzyme inhibitors and angiotensin receptor blockers over time
... 896 (88) N/A 888 (83) 906 (88) 893 (86) 873 (75) n (%) n (%) n (%) n (%) n (%) n (%) Female sex 44 (55) 5 (4) 28 (60) 21 (45) 19 (54) 9 (75) ApoE4 carrier 17 (21) 4 (29) 11 (23) 10 (21) 8 (23) 3 (25) Type 2 diabetes 33 ...
28
The Significance of Angiotensin Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Use in Sudden Cardiac Death
... of angiotensin converting enzyme (ACE) inhibitor or angiotensin II receptor blocker (ARB) and hyperkalemia in patients diagnosed with sudden cardiac ...
8
A pilot clinical trial of recombinant human angiotensin converting enzyme 2 in acute respiratory distress syndrome
... Abbreviations ACE2: Angiotensin-converting enzyme 2; AE: Adverse event; ALI: Acute lung injury; Ang: Angiotensin; ARDS: Acute respiratory distress syndrome; AT1R: Angiotensin type I rece[r] ...
9
Role of angiotensin-converting enzyme in myeloid cell immune responses
... BM is a complex and highly organized system that produces all circulating cells. How- ever, hematopoiesis is tightly regulated by a variety of factors including enzymes, recep- tors, hormones, cytokines, growth factors ...
12
Effective treatment of hypertension by recombinant Lactobacillus plantarum expressing angiotensin converting enzyme inhibitory peptide
... ACE: angiotensin converting enzyme; ACEIP: angiotensin converting enzyme inhibitory peptides; RAS: renin-angiotensin system; LAB: lactic acid bacteria; SppIP: sakasin-P; SHR: ...
9
Impact of I/D polymorphism of angiotensin converting enzyme (ACE) gene on myocardial infarction susceptibility among young Moroccan patients
... not angiotensin II plasma levels [34, ...in angiotensin II production, not ACE ...that angiotensin II can affect vascular smooth muscle growth in cell culture [37], however, only hyper- plasia is ...
6
Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD
... ated with a reduction in the risk of pneumonia (adjusted odds ratio, 0.75; 95% CI, 0.65–0.86). In contrast, a case-crossover study using the Taiwan Longitudinal Health Insurance Data- base found that neither the use of ...
8
Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels
... [18]. Angiotensin 2 increases proliferation of early erythroid progenitors but not the progenitors of other cell lines and ARB completely abolishes this effect ...
6
Angiotensin II: a new therapeutic option for vasodilatory shock
... Abstract: Angiotensin II (Ang II), part of the renin–angiotensin–aldosterone system (RAS), is a potent vasoconstrictor and has been recently approved for use by the US Food and Drug Administration in ...
12
Lack of Association between ACE I/D and AGTR1 A1166C Gene Polymorphisms and Preeclampsia in Turkish Pregnant Women of Trakya Region
... Renin, Angiotensin I (ANG I), Angiotensin Converting Enzyme (ACE), Angiotensin II (ANG II), and Angiotensin II Coupled Receptors which are members of the G protein-coupled receptor ...
5
SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease
... It has been reported that Aldosterone contributes to renal injury. MRAs have effect on renoprotection by reducing the concentration of aldosterone in DKD patients. But MRAs are limited by notable side effect ...
11
“A Class Review on ACE Inhibitors/ARBS and Beta Blockers and Effectiveness in HFrEF” by Rakhi K R, Dhandapani Chidambaram, Aleena Alex, Ann Merry Davis, Bharathi K, Keerthanaa B, India.
... of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers and ...function. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β ...
5
The risks and benefits of patients temporarily discontinuing medications in the event of an intercurrent illness: a systematic review protocol
... diuretics, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/direct renin inhibitors, NSAIDs and metformin; experiencing an intercurrent illness; or undergoing a ...
6
First-line treatment of hypertension: critical appraisal of potential role of aliskiren and hydrochlorothiazide in a fixed combination
... Abstract: Arterial hypertension is one of the major diseases in the Western world. It is an independent cardiovascular risk factor and is associated with increased morbidity and mortality. Several drug classes have been ...
8
Aliskiren and valsartan combination therapy for the management of hypertension
... an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin receptor blocker (ARB), plus a calcium channel blocker or thiazide diuretic are the most effective, well-tolerated, and proven ...
12
Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study
... ACE-I: Angiotensin converting enzyme inhibitor; AJCC: American Joint Committee on Cancer; AngII: Angiotensin II; ARB: Angiotensin receptor blocker; BB: Beta blocker; BMI: Body mass index; CAD: ...
9